Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 18, 2023
Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansUlrik Jurva, Lars Weidolf, Ann-Sofie Sandinge, et al.
Chemical Research in Toxicology|June 1, 2012
In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugsRichard A Thompson, Emre M Isin, Yan Li, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 2, 2021
Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy SubjectsAnn Aurell Holmberg, Lars Weidolf, Sofia Necander, et al.
Pharmacology Research & Perspectives|October 14, 2024
Disposition of orally administered atuliflapon, a novel 5-lipoxygenase-activating protein inhibitor in healthy participantsXue-Qing Li, Bo Lindmark, Carl Amilon, et al.
Regulatory Toxicology and Pharmacology : RTP|November 18, 2019
Qualification of impurities based on metabolite dataLars Weidolf, Thomas Andersson, Joel P Bercu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 13, 2023
Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in HumansChandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A Bragg, et al.
Pageof 4